Andrea L. Webber

6.7k total citations · 1 hit paper
28 papers, 1.5k citations indexed

About

Andrea L. Webber is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andrea L. Webber has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Andrea L. Webber's work include Cancer Immunotherapy and Biomarkers (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Genetic Syndromes and Imprinting (4 papers). Andrea L. Webber is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Genetic Syndromes and Imprinting (4 papers). Andrea L. Webber collaborates with scholars based in United States, France and Japan. Andrea L. Webber's co-authors include Mary E. Brunkow, Marisa S. Bartolomei, S M Tilghman, Jonathan A. Epstein, Jonathan A. Raper, Jia Li, Christopher B. Brown, Leonard Feiner, Shirley M. Tilghman and Min Lü and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Andrea L. Webber

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic mechanisms underlying the imprinting of the mouse H19 gene.

1993 408 citations Marisa S. Bartolomei, Andrea L. Webber et al. profile →

Peers

Countries citing papers authored by Andrea L. Webber

Since Specialization

Citations

This map shows the geographic impact of Andrea L. Webber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea L. Webber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea L. Webber more than expected).

Fields of papers citing papers by Andrea L. Webber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea L. Webber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea L. Webber. The network helps show where Andrea L. Webber may publish in the future.

Co-authorship network of co-authors of Andrea L. Webber

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea L. Webber. A scholar is included among the top collaborators of Andrea L. Webber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea L. Webber. Andrea L. Webber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between beta-catenin (CTNNB1) mutations and clinical outcomes of pembrolizumab in advanced hepatocellular carcinoma (aHCC): Exploratory analyses from KEYNOTE-240. 2024 ·Journal of Clinical Oncology ·Masatoshi Kudo, Ann‐Lii Cheng, Philippe Merle, Baek‐Yeol Ryoo, Thomas Decaens, İrfan Çiçin, Olav Dajani, Raed Moh’d Taiseer Al-Rajabi, Jean‐Marie Péron, Stephen L. Chan, Jennifer J. Knox, (unknown), (unknown), Andrea L. Webber, Carol E. Peña, Răzvan Cristescu, Cai Chen, Ken Hatogai, Abby B. Siegel, Richard S. Finn	1
2	Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma 2024 ·ESMO Open ·Min Hee Hong, (unknown), Thanh‐Trung Vo, Jae‐Keun Cho, (unknown), Se‐Hoon Lee, Sung‐Hwan Kim, Huaqiang Zhou, (unknown), Yoon Woo Koh, Sun Och Yoon, Andrea L. Webber, (unknown), Byoung Chul Cho, (unknown)	2
3	A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors 2024 ·Investigational New Drugs ·Maxime Chénard-Poirier, Aaron R. Hansen, Martin Gutierrez, Drew Rasco, Yan Xing, Lin‐Chi Chen, Heng Zhou, Andrea L. Webber, Tomoko Freshwater, Manish Sharma	2
4	Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors 2023 ·Investigational New Drugs ·Anastasios Stathis, Anthony W. Tolcher, (unknown), Daniel J. Renouf, Lin‐Chi Chen, (unknown), Tomoko Freshwater, Andrea L. Webber, Tapan K. Nayak, Lillian L. Siu	11
5	Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Daniel V. Paone, Kausik K. Nanda, Jing Li, (unknown), (unknown), Jun Lü, S.M. Soisson, R. Robinson, John W. Fisher, Andrea L. Webber, Gregg Wesolowski, Bennett Ma, Le T. Duong, Steven S. Carroll, Christopher S. Burgey, Shawn J. Stachel	6
6	Abstract 4217: Tumor mutational burden (TMB), T cell-inflamed gene expression profile (GEP) and PD-L1 are independently associated with response to pembrolizumab (Pembro) in patients with advanced melanoma in the KEYNOTE (KN)-006 study 2019 ·Cancer Research ·Antoni Ribas, Caroline Robert, Jacob Schachter, Georgina V. Long, Ana Arance, Matteo S. Carlino, James Larkin, Andrea L. Webber, Jared Lunceford, Qing Zhao, Răzvan Cristescu, Michael Nebozhyn, Chunsheng Zhang, Wendy M. Blumenschein, Clemens Krepler, Nageatte Ibrahim, Adil Daud, Jean‐Jacques Grob	8
7	Abstract LB-339: Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC) 2018 ·Cancer Research ·Tanguy Y. Seiwert, Robert I. Haddad, Joshua Bauml, Jared Weiss, David G. Pfister, Shilpa Gupta, Ranee Mehra, Iris Gluck, Hyunseok Kang, Francis P. Worden, Joseph P. Eder, Makoto Tahara, Barbara Burtness, Stephen V. Liu, Andrea L. Webber, Lingkang Huang, Robin Mogg, Răzvan Cristescu, Jonathan D. Cheng, Laura Q.M. Chow	34
8	The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease 2017 ·Scientific Reports ·Sophie C. Cazanave, Alexei A. Podtelezhnikov, (unknown), Mulugeta Seneshaw, Divya P. Kumar, Hae‐Ki Min, Prasanna K. Santhekadur, Bubu A. Banini, Adolfo G Mauro, Abdul M. Oseini, Robert Vincent, Keith Q. Tanis, Andrea L. Webber, Liangsu Wang, Pierre Bédossa, Faridoddin Mirshahi, Arun J. Sanyal	50
9	Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation 2016 ·Antiviral Research ·Sai Vikram Vemula, (unknown), (unknown), Bang-Lin Wan, (unknown), (unknown), Rosa I. Sánchez, David M. Tellers, Richard J. O. Barnard, Wade Blair, Daria J. Hazuda, Andrea L. Webber, Bonnie J. Howell	17
10	Gene expression analysis in serial liver fine needle aspirates 2014 ·Journal of Viral Hepatitis ·Serguei Lejnine, Matthew J. Marton, (unknown), Bonnie J. Howell, Andrea L. Webber, (unknown), Norah J. Shire, (unknown), Jared Lunceford, Marija Zeremski, Amy Sun, M. Ruddy, Andrew H. Talal	7
11	International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology 2012 ·Pharmacological Reviews ·Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, John J. Renger, Christopher J. Winrow	135
12	Pharmacological Validation of Candidate Causal Sleep Genes Identified in an N2 Cross 2011 ·Journal of Neurogenetics ·(unknown), Anthony L. Gotter, Joshua Millstein, Susan L. Garson, (unknown), Steven V. Fox, Alan T. Savitz, He S. Yang, (unknown), (unknown), (unknown), Andrea L. Webber, Martha Hotz Vitaterna, Andrew Kasarskis, Victor N. Uebele, Fred W. Turek, John J. Renger, Christopher J. Winrow	7
13	Dual role of Nr2e3 in photoreceptor development and maintenance 2008 ·Experimental Eye Research ·Andrea L. Webber, Paul Hodor, Catherine J. Thut, Thomas Vogt, Theresa Zhang, Daniel Holder, Konstantin Petrukhin	38
14	Identification of potent agonists of photoreceptor-specific nuclear receptor (NR2E3) and preparation of a radioligand 2006 ·Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg, Zhijian Zhao, Marianna Kapitskaya, Andrea L. Webber, Konstantin Petrukhin, Yui S. Tang, Dennis Dean, George D. Hartman, Craig W. Lindsley	27
15	Haploinsufficiency Is Not the Key Mechanism of Pathogenesis in a HeterozygousElovl4Knockout Mouse Model of STGD3 Disease 2006 ·Investigative Ophthalmology & Visual Science ·Dorit Raz-Prag, Radha Ayyagari, Robert N. Fariss, Md Nawajes A. Mandal, Vidyullatha Vasireddy, Sharon Majchrzak, Andrea L. Webber, Ronald A. Bush, Norman Salem, Konstantin Petrukhin, Paul A. Sieving	41
16	A High-Resolution Radiation Hybrid Map of the Proximal Portion of Mouse Chromosome 5 2000 ·Genomics ·Lisa M. Tarantino, Leonard Feiner, Alireza Alavi, Tim Wiltshire, Belén Hurlé, David M. Ornitz, Andrea L. Webber, Jonathan A. Raper, Andreas Lengeling, Lucy B. Rowe, Maja Bućan	7
17	RS‐127445: a selective, high affinity, orally bioavailable 5‐HT_2B receptor antagonist 1999 ·British Journal of Pharmacology ·Douglas W. Bonhaus, Lee A. Flippin, Robert Greenhouse, (unknown), (unknown), Mark A. Dawson, (unknown), Leon Chang, (unknown), Andrea L. Webber, Edward Leung, Richard M. Eglen, Graeme R. Martin	95
18	The Absence of Enhancer Competition betweenIgf2 and H19 following Transfer into Differentiated Cells 1998 ·Molecular and Cellular Biology ·Andrea L. Webber, Shirley M. Tilghman	8
19	Location of enhancers is essential for the imprinting of H19 and Igf2 genes 1998 ·Nature ·Andrea L. Webber, Robert S. Ingram, John M. Levorse, Shirley M. Tilghman	106
20	Parental Imprinting of the H19 and Igf2 Genes in the Mouse 1993 ·Cold Spring Harbor Symposia on Quantitative Biology ·S M Tilghman, Marisa S. Bartolomei, Andrea L. Webber, Mary E. Brunkow, Jennifer Saam, Philip A. Leighton, Karl Pfeifer, Sharon Zemel	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact